Theranos Care unit of Sarvodaya Hospital, Faridabad has become the first center in the Indian subcontinent to offer Terbium-161 therapy in India for patients with metastatic castration-resistant prostate cancer (mCRPC) and metastatic neuroendocrine tumors (NET) who have not responded to Lutetium-PSMA…
Terbium-161 Radionuclide Therapy in Cancer: A Promising Innovation in Nuclear Medicine
Cancer treatment has evolved significantly over the years, with targeted radionuclide therapy emerging as a revolutionary approach. Among the latest advancements in nuclear medicine is “Terbium-161 radionuclide therapy”, which holds tremendous potential for treating various types of cancer, particularly prostate cancer…